Investigating cancer disparities and global equity in Black populations
Official title: SAMBAI - Bridging Research Investigations of cancer Disparities and Global Equity (BRIDGE)
Funded at Emory University · NIH-11047003 · Data updated 2026-11-12
This study is looking into why Black patients, especially those from West Africa, tend to have more aggressive cancers like prostate, breast, and pancreatic cancer, and it aims to find ways to improve cancer care for these communities by exploring the role of genetics, environment, and social factors.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project start | May 1, 2024 |
| Project end | April 30, 2026 |
| Funding year | 2024 |
| Award (this year) | $316,465 |
| NIH project number | 1OT2CA297571-01 |
| Project ID | NIH-11047003 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include Black individuals, particularly those with a family history of aggressive cancers or those living in West African regions.
✕Less likely to help
Patients who do not identify as Black or who do not have a history of the targeted cancers may not receive direct benefits from this research.
What this research studies
This research focuses on understanding the higher rates of aggressive cancers, such as prostate, breast, and pancreatic cancers, in Black patients, particularly those from West Africa. The team will analyze genetic, environmental, and social factors that contribute to these disparities, using advanced genomic techniques and a biobank to gather comprehensive data. By collaborating with scientists from the US, Africa, and the UK, the project aims to create a resource that will help identify the causes of these disparities and improve cancer outcomes for marginalized populations.
Why it matters
Potential benefit: If successful, this research could lead to improved cancer prevention and treatment strategies tailored for Black populations, ultimately reducing health disparities.
How similar studies have gone: Previous research has shown success in addressing cancer disparities through genomic and environmental studies, indicating a promising approach for this project.
Where this research is happening
-
Emory University
Atlanta, United States Active
Researchers
- Principal investigator: Mccullough, Lauren E — Emory University
- Study coordinator: Mccullough, Lauren E
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.